Title | Decoy oligodeoxynucleotide characterization of transcription factors controlling endothelin-B receptor expression in vascular smooth muscle cells. |
Publication Type | Journal Article |
Year of Publication | 2000 |
Authors | Wagner AH, Krzesz R, Gao D, Schroeder C, Cattaruzza M, Hecker M |
Journal | Mol Pharmacol |
Volume | 58 |
Issue | 6 |
Pagination | 1333-40 |
Date Published | 2000 Dec |
ISSN | 0026-895X |
Keywords | Animals, Antioxidants, Aorta, Cells, Cultured, Gene Expression Regulation, Male, Mesenteric Arteries, Muscle, Smooth, Vascular, Oligodeoxyribonucleotides, Pyrrolidines, Rats, Rats, Wistar, Receptor, Endothelin B, Receptors, Endothelin, Thiocarbamates, Transcription Factors |
Abstract | Endothelin-1 is not only a powerful vasoconstrictor but also a potent mitogen for vascular smooth muscle cells (SMC), acting through both the endothelin-A and endothelin-B receptor (ET(B)-R). Although vascular SMC are known to express the ET(B)-R, its transcriptional regulation has not been studied thus far. Here we demonstrate that the potent inhibitor of nuclear factor kappaB activation, pyrrolidine dithiocarbamate (PDTC; 30-100 microM), induces de novo ET(B)-R expression in rat aortic and mesenteric cultured SMC. Electrophoretic mobility shift analyses revealed that besides inhibition of nuclear factor kappaB, PDTC enhances activator protein-1 (AP-1), CCAAT/enhancer-binding protein (C/EBP), and GATA-2 activity in these cells. Preincubation of PDTC-stimulated cells with appropriate decoy oligodeoxynucleotides confirmed the involvement of these three transcription factors, namely that of AP-1, in ET(B)-R expression. The stimulatory effect of PDTC on ET(B)-R expression was also confirmed functionally by monitoring an enhanced ET-1-induced apoptosis in PDTC-treated cells that was sensitive to the ET(B)-R antagonist, BQ788. Taken together, these findings demonstrate that C/EBP, GATA-2, and in particular AP-1 can control ET(B)-R expression in vascular SMC. They further support the notion that ET(B)-R expression in these cells may play an important role in cardiovascular complications, such as restenosis following angioplasty that in the early phase is characterized by prominent SMC apoptosis. |
DOI | 10.1124/mol.58.6.1333 |
Alternate Journal | Mol Pharmacol |
PubMed ID | 11093771 |